20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Vertex Pharmaceuticals Inc / Ma (VRTX)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
14 Best Medical Stocks To Invest In According to Hedge Funds
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Top 5 CRISPR Stocks To Invest In
Exact Sciences Corporation (NASDAQ:EXAS) specializes in cancer screening and diagnostic test products, operating both in the United States and internationally.
30 Most Valuable Drug Companies in 2024
In this article, we will take a look at the 30 most valuable drug companies in 2024.
What Gives Vertex Pharmaceuticals Incorporated (VRTX) a Significant Competitive Advantage?
Harding Loevner, an asset management company, released its “Global Equity Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode.
12 S&P 500 Stocks On the Move
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
5 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
30 Largest Pharmaceutical Companies in the World
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Jim Simons Stock Portfolio: 10 Top Stock Picks
In June this year, Stony Brook University, a public college in New York, saw the endowment fund it had swell from $370 million to more than $1 billion overnight, thanks in large part to a $500 million...
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
